SUN PHARMACEUTICAL INDUSTRIES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,495 INR | -1.78% |
|
-0.50% | +18.67% |
ETFs positioned on Sun Pharmaceutical Industries Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 0 M€ | +0.45% | - | |
| 0.01% | 0 M€ | +0.44% | - | |
| 0.00% | 7 M€ | +0.11% | - |
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows:
- generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment;
- other (6%) : primarily active pharmaceutical ingredients.
At the end of March 2021, the group had 44 production plants worldwide.
Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Sector
Pharmaceuticals
Calendar
2024-05-23
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
1,495
INR
Average target price
1,574
INR
Spread / Average Target
+5.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.67% | 43.74B | |
| +21.99% | 22.26B | |
| +16.41% | 14.9B | |
| +9.03% | 13.39B | |
| +40.48% | 12.12B | |
| -9.64% | 6.92B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.13% | 5.47B | |
| +9.14% | 4.83B |
- Stock Market
- Equities
- SUNPHARMA Stock
- Funds and ETFs Sun Pharmaceutical Industries Ltd.